Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

BTIG analyst Marie Thibault said she previously expected Abbott’s electrophysiology division to slow down, but the opposite occurred, as strength in its heart-mapping technology doctors use in ...

Abbott’s electrophysiology business also fared well, posting $629m in global sales. The company entered the lucrative pulsed ...

"The launch of Abbott's Volt PFA system marks a major milestone in the evolution of electrophysiology across Europe and signals we're moving beyond early therapy approaches to new systems that ...

The Volt PFA System builds upon Abbott's leading electrophysiology (EP) portfolio by providing a single-catheter PFA approach, improving workflow by allowing for mapping, pacing, and ablating with ...

Abbott Labs recorded higher earnings and revenue in the first quarter as strong demand for its nutritional products and medical devices offset weakness in other segments. The healthcare products ...

Abbott's diversified global supply chain and 25 new products in the pipeline position it well to navigate tariff impacts and ...

Abbott Laboratories (ABT) reports robust earnings with a 12.5% increase in medical devices sales and a 7% rise in nutrition, ...

CEO Robert Ford noted that Abbott has 90 manufacturing locations worldwide, with plants close to customers, redundancy, and ...